Tesamorelin + Ipamorelin Blend

Description

Tesamorelin + Ipamorelin 11mg/6mg Blend (Dual GHRH/Ghrelin Receptor Agonist Synergy)

Concentration: 11 mg Tesamorelin + 6 mg Ipamorelin per vial
Form: Lyophilized Powder
Storage: Store at −20 °C. Protect from light and moisture.

Molecular Formula (Tesamorelin): C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: 5,006.36 g/mol
Molecular Formula (Ipamorelin): C₃₈H₄₉N₉O₅
Molecular Weight: 711.86 g/mol
Purity: ≥98% (HPLC)

Description

The Tesamorelin + Ipamorelin 11mg/6mg Blend is a dual-pathway growth hormone secretagogue combination engineered to replicate natural hypothalamic and pituitary signaling with enhanced amplitude and duration of GH release.

• Tesamorelin, a stabilized GHRH analog, binds to the pituitary GHRH receptor, initiating cAMP-mediated GH synthesis and pulsatile secretion while sustaining a prolonged half-life and increased IGF-1 production.

• Ipamorelin, a selective GHSR-1a (ghrelin receptor) agonist, complements this effect by triggering calcium-mediated GH exocytosis, amplifying the amplitude and frequency of GH pulses with minimal impact on prolactin or cortisol levels.

Together, these peptides form a high-potency synergistic system that mirrors physiological GH rhythms while promoting endocrine balance, metabolic efficiency, and tissue recovery.
This combination provides a robust platform for exploring dual-axis modulation of growth hormone release and IGF-1-driven anabolic signaling.

Intended Use

This product is intended for laboratory research use only.
It is not for human consumption, diagnostic, or therapeutic applications.
All handling should be performed by qualified professionals in a controlled research environment.

Key Research Applications

• Investigation of dual GHRH and GHSR-1a activation and feedback integration

• Studies on GH/IGF-1 axis regulation and metabolic rate modulation

• Research on synergistic GH pulse amplitude and recovery physiology

• Analysis of endocrine optimization and long-acting peptide combinations